AdjuCor

AdjuCor

Adjucor develops a cardiac-assist device for advanced heart failure patients. The device maintains the heart's function while avoiding blood contact. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD247m (Public information from Mar 2022)
Company register number HRB 183620 (München)
Munich Bavaria (HQ)

Financials

Estimates*

Edit
  • Edit
DateInvestorsAmountRound
N/A

€1.6m

Seed
N/A

€336k

Grant
N/A

€905k

Grant
N/A

€550k

Grant
N/A

€94.0k

Grant
N/A

€2.5m

Seed
N/A

€266k

Grant
N/A

€75.0k

Grant
N/A

€3.4m

Series A
N/A

€256k

Grant
N/A

€2.2m

Series A
N/A

€2.0m

Series A

€29.0m

Series B

€2.5m

Grant

N/A

Valuation: €145m

1254.9x EV/LTM Revenues

Early VC
Total FundingAUD77.5m

Recent News about AdjuCor

Edit
More about AdjuCor
Edit

Developer of a heart assist device designed to assist patients with advanced heart problems. The company utilizes technology that covers the diseased heart and supports it in its function and develops a device that assists the heart while completely avoiding the complication-laden aspect of blood contact, enabling healthcare professionals to enhance the care of patients with heart failure and improve their quality of life.s

Keywords: Healthcare Devices, Services, Supplies, Healthcare Tech, Heart Assisting Device, Heart Assisting Technology, Heart Failure, Heart Failure Treatment, Implantable Device, Med Tech, Medical Device.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.